TLR2/6 agonists and interferon-gamma induce human melanoma cells to produce CXCL10.

Mauldin, Ileana S; Wang, Ena; Deacon, Donna H; Olson, Walter C; Bao, Yongde; Slingluff, Craig L

Mauldin, Ileana S; Wang, Ena; Deacon, Donna H; Olson, Walter C; Bao, Yongde; Slingluff, Craig L.

Afiliación

Mauldin IS; Department of Surgery, University of Virginia, Charlottesville, VA.
Wang E; Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD.
Deacon DH; Department of Surgery, University of Virginia, Charlottesville, VA.
Olson WC; Department of Surgery, University of Virginia, Charlottesville, VA.
Bao Y; Department of Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA.
Slingluff CL; Department of Surgery, University of Virginia, Charlottesville, VA.

Int J Cancer ; 137(6): 1386-96, 2015 Sep 15.

Article en En | MEDLINE | ID: mdl-25765738

Asunto(s)

Antineoplásicos/farmacología; Quimiocina CXCL10/metabolismo; Interferón gamma/metabolismo; Melanoma/metabolismo; Receptor Toll-Like 2/agonistas; Receptor Toll-Like 6/agonistas; Línea Celular Tumoral; Humanos; Linfocitos T/efectos de los fármacos; Linfocitos T/metabolismo; Regulación hacia Arriba/efectos de los fármacos

Palabras clave

immune therapy; melanoma; migration; toll-like receptor; tumor infiltration

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Interferón gamma / Receptor Toll-Like 2 / Receptor Toll-Like 6 / Quimiocina CXCL10 / Melanoma / Antineoplásicos Límite: Humans Idioma: En Revista: Int J Cancer Año: 2015 Tipo del documento: Article País de afiliación: Ciudad del Vaticano

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google